{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:24:07Z","timestamp":1791584647422,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2020QNA7005"],"award-info":[{"award-number":["2020QNA7005"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073750"],"award-info":[{"award-number":["82073750"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20409"],"award-info":[{"award-number":["U20A20409"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nano.2021.102443","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T08:22:43Z","timestamp":1627028563000},"page":"102443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Xiaoyue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6382","key":"10.1016\/j.nano.2021.102443_bb0005","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science."},{"issue":"21","key":"10.1016\/j.nano.2021.102443_bb0010","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1158\/1078-0432.CCR-18-0142","article-title":"Induction of neoantigen-specific cytotoxic T cells and construction of T-cell receptor\u2013engineered T cells for ovarian cancer","volume":"24","author":"Matsuda","year":"2018","journal-title":"Clin Cancer Res."},{"issue":"6449","key":"10.1016\/j.nano.2021.102443_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.aav8692","article-title":"Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor","volume":"365","author":"Ma","year":"2019","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.nano.2021.102443_bb0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/2326-6066.CIR-17-0559","article-title":"Tumor immunity and survival as a function of alternative neopeptides in human cancer","volume":"6","author":"Rech","year":"2018","journal-title":"Cancer Immunol Res."},{"issue":"10","key":"10.1016\/j.nano.2021.102443_bb0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med."},{"issue":"6230","key":"10.1016\/j.nano.2021.102443_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science."},{"key":"10.1016\/j.nano.2021.102443_bb0035","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fimmu.2019.01392","article-title":"Determinants for neoantigen identification","volume":"10","author":"Garcia-Garijo","year":"2019","journal-title":"Frontiers in Immunology."},{"issue":"9","key":"10.1016\/j.nano.2021.102443_bb0040","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol."},{"issue":"3","key":"10.1016\/j.nano.2021.102443_bb0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology."},{"key":"10.1016\/j.nano.2021.102443_bb0050","first-page":"1","article-title":"A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction","author":"Mei","year":"2019","journal-title":"Brief Bioinform"},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nbt.3800","volume":"35","author":"The problem with neoantigen prediction","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2021.102443_bb0060","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","article-title":"Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction","volume":"46","author":"Abelin","year":"2017","journal-title":"Immunity."},{"issue":"7528","key":"10.1016\/j.nano.2021.102443_bb0070","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature."},{"issue":"10","key":"10.1016\/j.nano.2021.102443_bb0075","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1158\/2326-6066.CIR-19-0155","article-title":"Machine-learning prediction of tumor antigen immunogenicity in the selection of therapeutic epitopes","volume":"7","author":"Smith","year":"2019","journal-title":"Cancer Immunol Res."},{"issue":"W1","key":"10.1016\/j.nano.2021.102443_bb0080","doi-asserted-by":"crossref","first-page":"W502","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: immune epitope database-analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nano.2021.102443_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0091-679X(04)75021-9","article-title":"T-cell responses to cancer","volume":"75","author":"Lee","year":"2004","journal-title":"Methods Cell Biol."},{"issue":"7662","key":"10.1016\/j.nano.2021.102443_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature."},{"issue":"7662","key":"10.1016\/j.nano.2021.102443_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature."},{"issue":"7738","key":"10.1016\/j.nano.2021.102443_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature."},{"issue":"12","key":"10.1016\/j.nano.2021.102443_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1511506","article-title":"Trial watch: peptide-based vaccines in anticancer therapy","volume":"7","author":"Bezu","year":"2018","journal-title":"Oncoimmunology."},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/vaccines3020390","article-title":"CpG oligonucleotides as cancer vaccine adjuvants","volume":"3","author":"Shirota","year":"2015","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.nano.2021.102443_bb0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/IJN.S114477","article-title":"CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies","volume":"12","author":"Hanagata","year":"2017","journal-title":"Int J Nanomedicine."},{"key":"10.1016\/j.nano.2021.102443_bb0120","article-title":"Safety and immunogenicity of an anti-Zika virus DNA vaccine \u2014 preliminary report","author":"Tebas","year":"2017","journal-title":"N Engl J Med"},{"issue":"10008","key":"10.1016\/j.nano.2021.102443_bb0125","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.nano.2021.102443_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2016.05.004","article-title":"DNA vaccines to attack cancer: strategies for improving immunogenicity and efficacy","volume":"165","author":"Tiptiri-Kourpeti","year":"2016","journal-title":"Pharmacol Ther."},{"issue":"23","key":"10.1016\/j.nano.2021.102443_bb0135","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.vaccine.2010.03.040","article-title":"Biosafety of DNA vaccines: new generation of DNA vectors and current knowledge on the fate of plasmids after injection","volume":"28","author":"Faurez","year":"2010","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/hv.2.2.2620","article-title":"Preclinical and clinical safety studies on DNA vaccines","volume":"2","author":"Schalk","year":"2006","journal-title":"Hum Vaccin."},{"issue":"4","key":"10.1016\/j.nano.2021.102443_bb0145","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ymthe.2017.01.022","article-title":"A Novel DNA vaccine platform enhances neo-antigen-like T cell responses against WT1 to break tolerance and induce anti-tumor immunity","volume":"25","author":"Walters","year":"2017","journal-title":"Mol Ther."},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/2326-6066.CIR-18-0283","article-title":"G HH, Mandloi N, Barlow J, et al. A synthetic DNA, multi-neoantigen vaccine drives predominately MHC class I CD8(+) T-cell responses, impacting tumor challenge","volume":"7","author":"Duperret","year":"2019","journal-title":"Cancer Immunology Research."},{"issue":"5","key":"10.1016\/j.nano.2021.102443_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1026531","article-title":"Trial watch: naked and vectored DNA-based anticancer vaccines","volume":"4","author":"Bloy","year":"2015","journal-title":"Oncoimmunology."},{"issue":"3","key":"10.1016\/j.nano.2021.102443_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev Vaccines."},{"issue":"22","key":"10.1016\/j.nano.2021.102443_bb0165","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1158\/0008-5472.CAN-10-0699","article-title":"Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity","volume":"70","author":"Kreiter","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.nano.2021.102443_bb0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nature Review Cancer."},{"issue":"15","key":"10.1016\/j.nano.2021.102443_bb0175","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.molimm.2007.04.009","article-title":"Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines","volume":"44","author":"Yan","year":"2007","journal-title":"Mol Immunol."},{"issue":"46","key":"10.1016\/j.nano.2021.102443_bb0180","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.vaccine.2016.09.062","article-title":"Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines","volume":"34","author":"Jorritsma","year":"2016","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0005-2736(02)00348-6","article-title":"Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes","volume":"1561","author":"Tros de Ilarduya","year":"2002","journal-title":"Biochim Biophys Acta."},{"issue":"5","key":"10.1016\/j.nano.2021.102443_bb0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics."},{"issue":"9","key":"10.1016\/j.nano.2021.102443_bb0195","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.nano.2021.102443_bb0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol Evol."},{"issue":"1","key":"10.1016\/j.nano.2021.102443_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12920-017-0285-y","article-title":"Identification of trunk mutations in gastric carcinoma: a case study","volume":"10","author":"Zhou","year":"2017","journal-title":"BMC Med Genomics."},{"issue":"5","key":"10.1016\/j.nano.2021.102443_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/gix017","article-title":"PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity","volume":"6","author":"Liu","year":"2017","journal-title":"Gigascience."},{"issue":"4","key":"10.1016\/j.nano.2021.102443_bb0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics."},{"key":"10.1016\/j.nano.2021.102443_bb0220","doi-asserted-by":"crossref","unstructured":"Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 2019;47(D1):D339-D43.","DOI":"10.1093\/nar\/gky1006"},{"issue":"6","key":"10.1016\/j.nano.2021.102443_bb0225","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc."},{"issue":"5","key":"10.1016\/j.nano.2021.102443_bb0230","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-11-3722","article-title":"Exploiting the mutanome for tumor vaccination","volume":"72","author":"Castle","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.nano.2021.102443_bb0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/gt.2015.85","article-title":"Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator","volume":"23","author":"Chang","year":"2016","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nature Review Immunology."},{"issue":"5","key":"10.1016\/j.nano.2021.102443_bb0245","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00262-014-1523-1","article-title":"Interleukin 12: still a promising candidate for tumor immunotherapy?","volume":"63","author":"Lasek","year":"2014","journal-title":"Cancer Immunol Immunother."},{"issue":"11","key":"10.1016\/j.nano.2021.102443_bb0250","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.4049\/jimmunol.1200274","article-title":"Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma","volume":"189","author":"Kodumudi","year":"2012","journal-title":"J Immunol."},{"issue":"1","key":"10.1016\/j.nano.2021.102443_bb0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-019-0666-2","article-title":"Best practices for bioinformatic characterization of neoantigens for clinical utility","volume":"11","author":"Richters","year":"2019","journal-title":"Genome Med."},{"issue":"7095","key":"10.1016\/j.nano.2021.102443_bb0260","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04790","article-title":"Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells","volume":"441","author":"Williams","year":"2006","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.nano.2021.102443_bb0265","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat Med."},{"issue":"1","key":"10.1016\/j.nano.2021.102443_bb0270","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-18-1763","article-title":"Immunotherapy targeting HPV16\/18 generates potent immune responses in HPV-associated head and neck cancer","volume":"25","author":"Aggarwal","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"9","key":"10.1016\/j.nano.2021.102443_bb0275","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00262-016-1860-3","article-title":"Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma","volume":"65","author":"Hoeller","year":"2016","journal-title":"Cancer Immunol Immunother."},{"issue":"22","key":"10.1016\/j.nano.2021.102443_bb0280","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1056\/NEJMoa1012863","article-title":"gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma","volume":"364","author":"Schwartzentruber","year":"2011","journal-title":"N Engl J Med."},{"issue":"38","key":"10.1016\/j.nano.2021.102443_bb0285","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1016\/j.vaccine.2015.07.081","article-title":"A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model","volume":"33","author":"Gupta","year":"2015","journal-title":"Vaccine."},{"issue":"6","key":"10.1016\/j.nano.2021.102443_bb0290","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12026-019-09111-w","article-title":"Promotion on NLRC5 upregulating MHC-I expression by IFN-gamma in MHC-I-deficient breast cancer cells","volume":"67","author":"Zhao","year":"2019","journal-title":"Immunol Res."},{"issue":"2","key":"10.1016\/j.nano.2021.102443_bb0295","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2567.2000.00964.x","article-title":"CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12","volume":"99","author":"Kranzer","year":"2000","journal-title":"Immunology."},{"issue":"4","key":"10.1016\/j.nano.2021.102443_bb0300","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","article-title":"T-Scan: a genome-wide method for the systematic discovery of T cell epitopes","volume":"178","author":"Kula","year":"2019","journal-title":"Cell."},{"issue":"6","key":"10.1016\/j.nano.2021.102443_bb0305","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41563-018-0028-2","article-title":"A facile approach to enhance antigen response for personalized cancer vaccination","volume":"17","author":"Li","year":"2018","journal-title":"Nat Mater."},{"issue":"7528","key":"10.1016\/j.nano.2021.102443_bb0310","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature."}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:16:21Z","timestamp":1761549381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":62,"alternative-id":["S1549963421000861"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102443","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102443"}}